Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers
暂无分享,去创建一个
M Fujita | J. Seibyl | J. Staley | P. Maciejewski | S. Zoghbi | R. Innis | M. Fujita | S. Krishnan-Sarin | G. Tamagnan | J P Seibyl | R B Innis | P K Maciejewski | S Zoghbi | S O'Malley | J K Staley | S Krishnan-Sarin | G Tamagnan | Stephanie O'Malley | S. O'Malley
[1] L. Kozlowski,et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.
[2] T. Hökfelt,et al. On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons , 1979, Pharmacology Biochemistry and Behavior.
[3] D. Balfour. Influence of nicotine on the release of monoamines in the brain. , 1989, Progress in brain research.
[4] N. Volkow,et al. Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.
[5] T. Di Paolo,et al. Sex and estrous cycle variations of rat striatal dopamine uptake sites. , 1993, Neuroendocrinology.
[6] G. Goodwin,et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.
[7] L. Werling,et al. Nicotinic receptor‐mediated regulation of dopamine transporter activity in rat prefrontal cortex , 2000, Synapse.
[8] Robert B. Innis,et al. Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] H. Friedman,et al. The importance of measuring cotinine levels to identify smokers in clinical trials , 1994, Clinical pharmacology and therapeutics.
[10] S. Hall,et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. , 1996, Journal of consulting and clinical psychology.
[11] F I Carroll,et al. High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain , 1992, Synapse.
[12] C. Pomerleau,et al. Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. , 1994, Addictive behaviors.
[13] N. Volkow,et al. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. , 1998, Journal of addictive diseases.
[14] J. Aronstein,et al. Environmental conditions of residential electrical connections , 1998, Electrical Contacts - 1998. Proceedings of the Forty-Fourth IEEE Holm Conference on Electrical Contacts (Cat. No.98CB36238).
[15] L. Reneman,et al. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.
[16] C. Pelizzari,et al. Accurate Three‐Dimensional Registration of CT, PET, and/or MR Images of the Brain , 1989, Journal of computer assisted tomography.
[17] Marc Laruelle,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.
[18] Alexander Neumeister,et al. [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder , 2000, Biological Psychiatry.
[19] Carl J. Huberty,et al. Multivariate Analysis of Variance and Covariance , 2000 .
[20] G. Chiara,et al. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs , 1996, Nature.
[21] B. Winblad,et al. The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brain , 1987, Neurochemistry International.
[22] E Méndez-Alvarez,et al. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. , 1997, Life Science.
[23] T. Westfall,et al. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. , 1983, General pharmacology.
[24] T. Arinami,et al. A Synergistic Effect of Serotonin Transporter Gene Polymorphism and Smoking in Association with CHD , 1999, Thrombosis and Haemostasis.
[25] J. Hietala,et al. High levels of dopamine activity in the basal ganglia of cigarette smokers. , 2000, The American journal of psychiatry.
[26] R. Salín-Pascual,et al. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. , 1996, The Journal of clinical psychiatry.
[27] M. Bleecker,et al. The factor structure of the Profile of Mood States (POMS) and its relationship to occupational lead exposure. , 1999, Journal of occupational and environmental medicine.
[28] Eileen O. Smith,et al. Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.
[29] M. Kuhar,et al. [125I]RTI-55: a potent ligand for dopamine transporters. , 1991, European journal of pharmacology.
[30] L. Dwoskin,et al. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. , 1997, Biochemical pharmacology.
[31] I. Podreka,et al. Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT , 1997 .
[32] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[33] M. Morissette,et al. Effect of Chronic Estradiol and Progesterone Treatments of Ovariectomized Rats on Brain Dopamine Uptake Sites , 1993, Journal of neurochemistry.
[34] Robert B. Innis,et al. Evaluation of the monoamine uptake site ligand [131I]methyl 3β-(4-Iodophenyl)-tropane-2β-carboxylate ([123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI , 1993 .
[35] G. Cassano,et al. Effect of aging and sex on the [3H]-paroxetine binding to human platelets. , 1998, Journal of affective disorders.
[36] Ronald C. Kessler,et al. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. , 1994 .
[37] G. Fink,et al. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. , 1997, Brain research. Molecular brain research.
[38] M Laruelle,et al. Regional distribution of serotonergic pre‐ and postsynaptic markers in human brain , 1989, Acta psychiatrica Scandinavica. Supplementum.
[39] D. Charney,et al. Age-Related Decline in Striatal Dopamine Transporter Binding with Iodine-123-β-CITSPECT , 1995 .
[40] H. Schievelbein,et al. MECHANISM OF THE RELEASE OF AMINES BY NICOTINE , 1967 .
[41] M. Benwell,et al. The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain. , 1982, European journal of pharmacology.
[42] E F Domino,et al. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers , 2000, Synapse.
[43] J. Marcusson,et al. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.
[44] M. First,et al. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.
[45] I G Zubal,et al. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] S. Tiffany,et al. The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.
[47] G. Fink,et al. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. , 1999, Brain research. Molecular brain research.
[48] R. Rivest,et al. Brain dopamine transporter: gender differences and effect of chronic haloperidol , 1995, Brain Research.
[49] Marc Laruelle,et al. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.
[50] S M Dursun,et al. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. , 1999, Medical hypotheses.
[51] R. Kessler,et al. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. , 1997, Drug and alcohol dependence.
[52] S. Zoghbi,et al. Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. , 1994, Journal of pharmaceutical sciences.
[53] Linda Carpenter,et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.
[54] R. Wurtman,et al. Effects of systemic nicotine on serotonin release in rat brain , 1993, Brain Research.
[55] M. Picciotto. Common aspects of the action of nicotine and other drugs of abuse. , 1998, Drug and alcohol dependence.
[56] J. Court,et al. Distribution of nicotinic subtypes in human brain. , 1995, Alzheimer disease and associated disorders.
[57] A. Neale,et al. Neurobehavioral and health-related deficits in solvent-exposed painters. , 1996, American journal of industrial medicine.
[58] E. Perry,et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use , 1998, Neuroscience.
[59] J. Seibyl,et al. Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT , 2000, Neurobiology of Aging.
[60] J. Rausch,et al. Effect of nicotine on human blood platelet serotonin uptake and efflux , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[61] M. Jarvis,et al. Plasma cotinine: stability in smokers and validation of self-reported smoke exposure in nonsmokers. , 1994, Environmental research.
[62] D. Mash,et al. Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization , 1994, Journal of neurochemistry.